mp:Vdraft Sandbox: verschil tussen versies
Naar navigatie springen
Naar zoeken springen
Tekst vervangen door " __NUMBEREDHEADINGS__ {{DISPLAYTITLE:Medicatieproces 9.1: Voorbeelden doseringen}} = Voorbeelden doseringen = Deze paragraaf bevat uitgewerkte voorbeelden voor het concept..." Label: Vervangen |
Geen bewerkingssamenvatting |
||
| Regel 1: | Regel 1: | ||
__NUMBEREDHEADINGS__ | __NUMBEREDHEADINGS__ | ||
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]] | |||
=Addenda voor inhoudelijke gegevens= | |||
===Patiënt I. XXX_Jangi=== | |||
<section begin=XXX_Jangi /> | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patiënt | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="3" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgegevens | |||
|style="background-color: white;"|I. XXX_Jangi | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Knolweg 1002 9999ZZ Stitswerd 3 Woon-/verblijfadres | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Telefoonnummers | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Telefoonnummer | |||
|style="background-color: white;"|+31612345678 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Nummer soort | |||
|style="background-color: white;"|Telefoonnummer thuis (code = 'HP' in codeSystem 'HL7 AddressUse') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatienummer | |||
|style="background-color: white;"|999911727 [BSN] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatienummer | |||
|style="background-color: white;"|10009 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Geboortedatum | |||
|style="background-color: white;"|2 aug 1964 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Geslacht | |||
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
|}<section end=XXX_Jangi /><section begin=DG_XXX_Jangi /> | |||
====Documentgegevens XXX_Jangi ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Documentgegevens | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Document datum | |||
|style="background-color: white;"|T | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Auteur - zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="11"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Apotheek de Gulle Gaper | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Zalfstraat 6 1235BB Ons Dorp 5 Werkadres | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Telefoonnummers | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Telefoonnummer | |||
|style="background-color: white;"|+31703655424 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Nummer soort | |||
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'HL7 AddressUse') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Email adressen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Email adres | |||
|style="background-color: white;"|info@apotheekgullegaper.com | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Email soort | |||
|style="background-color: white;"|Zakelijk e-mailadres (code = 'WP' in codeSystem 'HL7 AddressUse') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verificatie patient | |||
|style="background-color: white;"|Nee | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verificatie zorgverlener | |||
|style="background-color: white;"|Nee | |||
|}<section end=DG_XXX_Jangi /><section begin=MBHS_XXX_Jangi /><section begin=MBH_MBH_MO_123_1 /> | |||
====Medicamenteuze behandeling MBH_MO_123_1 ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatie gebruik | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Registratiedatum | |||
|style="background-color: white;"|T, om 10:57 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 3 dagen, gedurende 3 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - Product specificatie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Product naam | |||
|style="background-color: white;"|Ibuprofen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T- 3 dagen, gedurende 3 dagen, 4 maal per dag 1 tablet, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|4 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Auteur | |||
|style="background-color: white;"|Patiënt | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Kopie indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toelichting | |||
|style="background-color: white;"|Pijn | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_MO_123_1 /><section begin=MBH_MBH_MO_123_2 /> | |||
====Medicamenteuze behandeling MBH_MO_123_2 ==== | |||
=== 1 maal per dag === | {| class="wikitable" width="85%" | ||
==== | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="5" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Afspraakdatum | |||
|style="background-color: white;"|T- 6 dagen, om 11:55 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 6 dagen, tot nader order | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="5"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatie nummer | |||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Apotheek De Gulle Gaper | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|Emovate zalf 0,5 mg/g (code = '400629' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|CLOBETASON ZALF 0,5MG/G (code = '65617' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|CLOBETASON ZALF 0,5MG/G (code = '115606' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="6"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Omschrijving | |||
|style="background-color: white;"|Vanaf T- 6 dagen, tot nader order, eerst 2 maal per dag zalf gedurende 7 dagen, daarna 1 maal per dag zalf gedurende 7 dagen, daarna 3 maal per week zalf gedurende 7 dagen, cutaan | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsweg | |||
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Doseerinstructie 1 | |||
|style="background-color: white;"|eerst gedurende 7 dagen 2 maal per dag | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Doseerinstructie 2 | |||
|style="background-color: white;"|dan gedurende 7 dagen 1 maal per dag | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Doseerinstructie 3 | |||
|style="background-color: white;"|dan gedurende 7 dagen 3 maal per week | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Toelichting | |||
|style="background-color: white;"|Eczeem oogleden | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_MO_123_2 /><section begin=MBH_MBH_MO_123_3 /> | |||
====Medicamenteuze behandeling MBH_MO_123_3 ==== | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="7" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="6" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="6"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_MO_123_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="6"|Afspraakdatum | ||
|style="background-color: white;"|Vanaf | |style="background-color: white;"|T- 15 dagen, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 15 dagen, gedurende 4 weken | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="7"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="10"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="6"|Zorgverlener | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="8"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Naamgegevens | ||
|style="background-color: white;"| | |style="background-color: white;"|John de Vries | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Specialisme | ||
|style="background-color: white;"| | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="5"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="6"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|GLIMEPIRIDE TABLET 3MG (code = '44458' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="6"| | |colspan="6"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|GLIMEPIRIDE TABLET 3MG (code = '98345' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="7"| | |colspan="7"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Omschrijving | |||
|style="background-color: white;"|Vanaf T- 15 dagen, gedurende 4 weken, 1 maal per dag 2 tabletten, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="5"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Kopie indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Toelichting | |||
|style="background-color: white;"|Exact 4 weken | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="5" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_3_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Afspraakdatum | |||
|style="background-color: white;"|T- 14 dagen, om 15:55 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 14 dagen, tot en met T+ 13 dagen, om 23:59 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="6"| | |colspan="6"|Verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="5"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatie nummer | |||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Apotheek De Gulle Gaper | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|Glimepiride activis tablet 3mg (code = '1753029' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|GLIMEPIRIDE TABLET 3MG (code = '44458' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|GLIMEPIRIDE TABLET 3MG (code = '98345' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Omschrijving | |||
|style="background-color: white;"|Vanaf T- 14 dagen, tot en met T+ 13 dagen, om 23:59, 1 maal per dag 2 tabletten, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 2 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie naar medicatieafspraak | |||
|style="background-color: white;"|MBH_MO_123_3_MA_1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatie gebruik | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Registratiedatum | |||
|style="background-color: white;"|T, om 12:58 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 10 dagen, tot en met T+ 1 dag, om 23:59 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - Product specificatie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Product naam | ||
|style="background-color: white;"|1 | |style="background-color: white;"|Glimepiride | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T- 10 dagen, tot en met T+ 1 dag, om 23:59, 1 maal per dag 1 tablet | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Auteur | |||
|style="background-color: white;"|Patiënt | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Kopie indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_MO_123_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|}<section end=MBH_MBH_MO_123_3 /><section begin=MBH_MBH_MO_123_4 /> | |||
====Medicamenteuze behandeling MBH_MO_123_4 ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="7" | Medicatieafspraak | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="6" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Afspraakdatum | |||
|style="background-color: white;"|T- 60 dagen, om 09:13 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 60 dagen, tot nader order | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="7"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="10"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Zorgverlener | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="8"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Naamgegevens | |||
|style="background-color: white;"|I. Ternist | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Specialisme | |||
|style="background-color: white;"|Medisch specialisten, inwendige geneeskunde (code = '0313' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="5"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="3"|Zorgaanbieder identificatienummer | ||
|style="background-color: white;"|00001113 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Antonius | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|INSULINE GLARGINE INJVLST 100E/ML (code = '121312' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INSULINE GLARGINE INJVLST 100E/ML (code = '128651' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"| | |colspan="7"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Omschrijving | |||
|style="background-color: white;"|Vanaf T- 60 dagen, tot nader order, 1 maal per dag 10IE, SUBCUTAAN | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Toedieningsweg | |||
|style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 10 internationale eenheid | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Kopie indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="5" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Afspraakdatum | |||
|style="background-color: white;"|T- 60 dagen, om 15:55 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 60 dagen, tot nader order | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="5"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatie nummer | |||
|style="background-color: white;"|13336578 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Poliapotheek Antonius | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|LANTUS SOLOSTAR INJ 100E/ML PEN 3ML (code = '1859226' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INSULINE GLARGINE INJVLST 100E/ML (code = '121312' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|INSULINE GLARGINE INJVLST 100E/ML (code = '128651' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Omschrijving | |||
|style="background-color: white;"|Vanaf T- 60 dagen, tot nader order, Elke dag om 9 uur 10IE, subcutaan | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsweg | |||
|style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Doseerinstructie | |||
|style="background-color: white;"|elke dag om 10 internationale eenheid | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Kopie indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie naar medicatieafspraak | |||
|style="background-color: white;"|MBH_MO_123_4_MA_1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_MO_123_4 /><section begin=MBH_MBH_MO_123_5 /> | |||
====Medicamenteuze behandeling MBH_MO_123_5 ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="5" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_5_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Afspraakdatum | |||
|style="background-color: white;"|T- 36 dagen, om 15:55 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 36 dagen, gedurende 90 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="5"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatie nummer | |||
|style="background-color: white;"|13336578 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Poliapotheek Antonius | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 8MG (code = '2105594' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '69523' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '117722' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Omschrijving | |||
|style="background-color: white;"|Vanaf T- 36 dagen, gedurende 90 dagen, 1 maal per dag 1 tablet, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Kopie indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatie gebruik | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_5_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Registratiedatum | |||
|style="background-color: white;"|T- 33 dagen, om 13:58 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Nee | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Nee | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 34 dagen, tot nader order | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Stoptype | |||
|style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 8MG (code = '2105594' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '69523' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '117722' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="3"|Omschrijving | ||
|style="background-color: white;"|1 | |style="background-color: white;"|Vanaf T- 34 dagen, tot nader order, gestaakt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gerelateerde afspraak : TA | |||
|style="background-color: white;"|MBH_MO_123_5_TA_1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Auteur | |||
|style="background-color: white;"|Patiënt | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Reden wijzigen of stoppen gebruik | |||
|style="background-color: white;"|Te sterk effect (code = '6' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Kopie indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toelichting | |||
|style="background-color: white;"|Gestopt vanwege bijwerkingen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_MO_123_5 /><section begin=MBH_MBH_MO_123_6 /> | |||
====Medicamenteuze behandeling MBH_MO_123_6 ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="7" | Medicatieafspraak | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="6" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_6_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Afspraakdatum | |||
|style="background-color: white;"|T- 728 dagen, om 09:13 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 728 dagen, tot nader order | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="7"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="10"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Zorgverlener | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="8"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Naamgegevens | |||
|style="background-color: white;"|John de Vries | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Specialisme | |||
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="7"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Omschrijving | |||
|style="background-color: white;"|Vanaf T- 728 dagen, tot nader order, 1 maal per dag 1 tablet 's avonds, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk 's avonds | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Kopie indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="5" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_6_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Afspraakdatum | |||
|style="background-color: white;"|T- 323 dagen, om 15:55 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 323 dagen, tot nader order | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="5"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatie nummer | |||
|style="background-color: white;"|13336578 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Poliapotheek Antonius | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Omschrijving | |||
|style="background-color: white;"|Vanaf T- 323 dagen, tot nader order, 1 maal per dag 2 tabletten 's avonds, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 2 stuks 's avonds | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Kopie indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie naar medicatieafspraak | |||
|style="background-color: white;"|MBH_MO_123_6_MA_1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatie gebruik | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_6_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Registratiedatum | |||
|style="background-color: white;"|T- 248 dagen, om 09:00 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Nee | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 248 dagen, tot nader order | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T- 248 dagen, tot nader order, 1 maal per dag 1 tablet 's avonds, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 dag | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Auteur | |||
|style="background-color: white;"|Zorgverlener : I. Ternist - Medisch specialisten, inwendige geneeskunde. Antonius | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Kopie indicator | |||
|style="background-color: white;"|Nee | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toelichting | |||
|style="background-color: white;"|Patiënt gebruikt niet volgens voorschrift | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatie gebruik | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_6_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Registratiedatum | |||
|style="background-color: white;"|T- 172 dagen, om 15:37 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruik indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Volgens afspraak indicator | |||
|style="background-color: white;"|Nee | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 248 dagen, tot en met T- 173 dagen, om 23:59 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Omschrijving | |||
|style="background-color: white;"|Vanaf T- 248 dagen, tot en met T- 173 dagen, om 23:59, 1 maal per dag 1 tablet 's avonds, oraal, gestopt | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk 's avonds | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gerelateerde afspraak : MA | |||
|style="background-color: white;"|MBH_MO_123_6_MA_1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Auteur | |||
|style="background-color: white;"|Patiënt | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toelichting | |||
|style="background-color: white;"|Veel last van jeuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_MO_123_6 /><section begin=MBH_MBH_MO_123_7 /> | |||
====Medicamenteuze behandeling MBH_MO_123_7 ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="7" | Medicatieafspraak | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="6" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_7_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Afspraakdatum | |||
|style="background-color: white;"|T+ 3 dagen, om 09:27 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T+ 3 dagen, tot en met T+ 17 dagen, om 23:59 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="7"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="10"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Zorgverlener | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="8"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Naamgegevens | |||
|style="background-color: white;"|John de Vries | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Specialisme | |||
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|Flucloxacilline capsule 500mg (code = '5274' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|Flucloxacilline capsule 500mg (code = '15466' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="7"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Omschrijving | |||
|style="background-color: white;"|Vanaf T+ 3 dagen, tot en met T+ 17 dagen, om 23:59, Elke 8 uur 1 capsule, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Kopie indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_7 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_MO_123_7 /><section begin=MBH_MBH_MO_123_8 /> | |||
====Medicamenteuze behandeling MBH_MO_123_8 ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="5" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_8_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Afspraakdatum | |||
|style="background-color: white;"|T- 28 dagen, om 11:50 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 29 dagen, om 23:59 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Stoptype | |||
|style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="5"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatie nummer | |||
|style="background-color: white;"|13336578 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Poliapotheek Antonius | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Reden afspraak | |||
|style="background-color: white;"|Beleidswijziging | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|Atorvastatine ranbaxy tablet filmomhuld 40 mg (code = '2230879' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE TABLET 40MG (ALS CA-ZOUT-3-WATER) (code = '98620' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|ATORVASTATINE TABLET 40MG (ALS CA-ZOUT-3-WATER) (code = '137219' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Omschrijving | |||
|style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 29 dagen, om 23:59, 1 maal per dag 2 tabletten 's avonds, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 2 stuks 's avonds | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Kopie indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Relatie naar medicatieafspraak | |||
|style="background-color: white;"|MBH_MO_123_8_MA_3 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_8 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_MO_123_8 /><section begin=MBH_MBH_MO_123_9 /> | |||
====Medicamenteuze behandeling MBH_MO_123_9 ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="7" | Medicatieafspraak | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="6" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_9_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Afspraakdatum | |||
|style="background-color: white;"|T- 45 dagen, om 11:50 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 31 dagen, om 23:59 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="7"|Voorschrijver | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="10"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Zorgverlener | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="8"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Naamgegevens | |||
|style="background-color: white;"|John de Vries | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Specialisme | |||
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatienummer | |||
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FLUCLOXACILLINE CAPSULE 500MG (code = '5274' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FLUCLOXACILLINE CAPSULE 500MG (code = '15466' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="7"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Omschrijving | |||
|style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 31 dagen, om 23:59, 1 keer per exact 8 uur 1 stuk, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Doseerinstructie | |||
|style="background-color: white;"|exact iedere 8 uur 1 stuk | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Kopie indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_9 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_MO_123_9 /><section begin=MBH_MBH_MO_123_10 /> | |||
====Medicamenteuze behandeling MBH_MO_123_10 ==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="5" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Identificatie | |||
|style="background-color: white;"|MBH_MO_123_10_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Afspraakdatum | |||
|style="background-color: white;"|T- 36 dagen, om 15:50 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Gebruiksperiode | |||
|style="background-color: white;"|Vanaf T- 56 dagen, tot en met T- 37 dagen, om 23:59 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Stoptype | |||
|style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="5"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Zorgaanbieder | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Zorgaanbieder identificatie nummer | |||
|style="background-color: white;"|13336578 (in identificerend systeem: URA) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Organisatie naam | |||
|style="background-color: white;"|Poliapotheek Antonius | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Reden afspraak | |||
|style="background-color: white;"|Geen of onvoldoende effect | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 4MG (code = '2105586' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PERINDOPRIL TABLET 4MG (ERBUMINE) (code = '29076' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PERINDOPRIL TABLET 4MG (ERBUMINE) (code = '75434' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="6"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Omschrijving | |||
|style="background-color: white;"|Vanaf T- 56 dagen, tot en met T- 37 dagen, om 23:59, 1 maal per dag 1 tablet 's morgens, oraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Toedieningsweg | |||
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Doseerinstructie | |||
|style="background-color: white;"|1 maal per dag 1 stuk 's ochtends | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Kopie indicator | |||
|style="background-color: white;"|Ja | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|MBH identificatie | |||
|style="background-color: white;"|MBH_MO_123_10 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|}<section end=MBH_MBH_MO_123_10 /><section end=MBHS_XXX_Jangi /> | |||
===Versiehistorie=== | |||
<section begin=versiehistorie /> | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="2" | Versiegegevens | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="1" width="25%"| Datum | |||
|| Beschrijving | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="1"|26 aug 2019 | ||
|style="background-color: white;"| | |style="background-color: white;"|[https://bits.nictiz.nl/browse/MM-477 Issue MM-477] - adressoort toegevoegd bij alle adressen | ||
|} | |} | ||
<section end=versiehistorie /> | |||
< | [[Categorie:Kwalificatie]] | ||
Versie van 22 mrt 2021 16:18
__NUMBEREDHEADINGS__

Addenda voor inhoudelijke gegevens
Patiënt I. XXX_Jangi
| Patiënt | |||
| Gegevenselement | Waarde | ||
| Naamgegevens | I. XXX_Jangi | ||
| Adresgegevens | Knolweg 1002 9999ZZ Stitswerd 3 Woon-/verblijfadres | ||
| Telefoonnummers | |||
| Telefoonnummer | +31612345678 | ||
| Nummer soort | Telefoonnummer thuis (code = 'HP' in codeSystem 'HL7 AddressUse') | ||
| Identificatienummer | 999911727 [BSN] | ||
| Identificatienummer | 10009 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
| Geboortedatum | 2 aug 1964 | ||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | ||
Documentgegevens XXX_Jangi
| Documentgegevens | ||||
| Gegevenselement | Waarde | |||
| Document datum | T | |||
| Auteur - zorgaanbieder | ||||
| Organisatie naam | Apotheek de Gulle Gaper | |||
| Adresgegevens | Zalfstraat 6 1235BB Ons Dorp 5 Werkadres | |||
| Telefoonnummers | ||||
| Telefoonnummer | +31703655424 | |||
| Nummer soort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'HL7 AddressUse') | |||
| Email adressen | ||||
| Email adres | info@apotheekgullegaper.com | |||
| Email soort | Zakelijk e-mailadres (code = 'WP' in codeSystem 'HL7 AddressUse') | |||
| Verificatie patient | Nee | |||
| Verificatie zorgverlener | Nee | |||
Medicamenteuze behandeling MBH_MO_123_1
| Medicatie gebruik | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_MO_123_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Registratiedatum | T, om 10:57 | |||
| Gebruik indicator | Ja | |||
| Gebruiksperiode | Vanaf T- 3 dagen, gedurende 3 dagen | |||
| Geneesmiddel - Product specificatie | ||||
| Product naam | Ibuprofen | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T- 3 dagen, gedurende 3 dagen, 4 maal per dag 1 tablet, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 4 maal per dag 1 stuk | |||
| Auteur | Patiënt | |||
| Kopie indicator | Ja | |||
| Toelichting | Pijn | |||
| MBH identificatie | MBH_MO_123_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
Medicamenteuze behandeling MBH_MO_123_2
| Toedieningsafspraak | |||||
| Gegevenselement | Waarde | ||||
| Identificatie | MBH_MO_123_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
| Afspraakdatum | T- 6 dagen, om 11:55 | ||||
| Gebruiksperiode | Vanaf T- 6 dagen, tot nader order | ||||
| Verstrekker | |||||
| Zorgaanbieder | |||||
| Zorgaanbieder identificatie nummer | 01236578 (in identificerend systeem: URA) | ||||
| Organisatie naam | Apotheek De Gulle Gaper | ||||
| Geneesmiddel - primaire code | Emovate zalf 0,5 mg/g (code = '400629' in codeSystem 'G-Standaard HPK') | ||||
| Geneesmiddel - generiekere code | CLOBETASON ZALF 0,5MG/G (code = '65617' in codeSystem 'G-Standaard PRK') | ||||
| Geneesmiddel - generiekere code | CLOBETASON ZALF 0,5MG/G (code = '115606' in codeSystem 'G-Standaard GPK') | ||||
| Gebruiksinstructie | |||||
| Omschrijving | Vanaf T- 6 dagen, tot nader order, eerst 2 maal per dag zalf gedurende 7 dagen, daarna 1 maal per dag zalf gedurende 7 dagen, daarna 3 maal per week zalf gedurende 7 dagen, cutaan | ||||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
| Doseerinstructie 1 | eerst gedurende 7 dagen 2 maal per dag | ||||
| Doseerinstructie 2 | dan gedurende 7 dagen 1 maal per dag | ||||
| Doseerinstructie 3 | dan gedurende 7 dagen 3 maal per week | ||||
| Toelichting | Eczeem oogleden | ||||
| MBH identificatie | MBH_MO_123_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||||
Medicamenteuze behandeling MBH_MO_123_3
| Medicatieafspraak | ||||||
| Gegevenselement | Waarde | |||||
| Identificatie | MBH_MO_123_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||||
| Afspraakdatum | T- 15 dagen, om 09:13 | |||||
| Gebruiksperiode | Vanaf T- 15 dagen, gedurende 4 weken | |||||
| Voorschrijver | ||||||
| Zorgverlener | ||||||
| Naamgegevens | John de Vries | |||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||||
| Zorgaanbieder | ||||||
| Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||||
| Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||||
| Geneesmiddel - primaire code | GLIMEPIRIDE TABLET 3MG (code = '44458' in codeSystem 'G-Standaard PRK') | |||||
| Geneesmiddel - generiekere code | GLIMEPIRIDE TABLET 3MG (code = '98345' in codeSystem 'G-Standaard GPK') | |||||
| Gebruiksinstructie | ||||||
| Omschrijving | Vanaf T- 15 dagen, gedurende 4 weken, 1 maal per dag 2 tabletten, oraal | |||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||||
| Doseerinstructie | 1 maal per dag 2 stuks | |||||
| Kopie indicator | Ja | |||||
| Toelichting | Exact 4 weken | |||||
| MBH identificatie | MBH_MO_123_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||||
| Toedieningsafspraak | |||||
| Gegevenselement | Waarde | ||||
| Identificatie | MBH_MO_123_3_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
| Afspraakdatum | T- 14 dagen, om 15:55 | ||||
| Gebruiksperiode | Vanaf T- 14 dagen, tot en met T+ 13 dagen, om 23:59 | ||||
| Verstrekker | |||||
| Zorgaanbieder | |||||
| Zorgaanbieder identificatie nummer | 01236578 (in identificerend systeem: URA) | ||||
| Organisatie naam | Apotheek De Gulle Gaper | ||||
| Geneesmiddel - primaire code | Glimepiride activis tablet 3mg (code = '1753029' in codeSystem 'G-Standaard HPK') | ||||
| Geneesmiddel - generiekere code | GLIMEPIRIDE TABLET 3MG (code = '44458' in codeSystem 'G-Standaard PRK') | ||||
| Geneesmiddel - generiekere code | GLIMEPIRIDE TABLET 3MG (code = '98345' in codeSystem 'G-Standaard GPK') | ||||
| Gebruiksinstructie | |||||
| Omschrijving | Vanaf T- 14 dagen, tot en met T+ 13 dagen, om 23:59, 1 maal per dag 2 tabletten, oraal | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
| Doseerinstructie | 1 maal per dag 2 stuks | ||||
| Relatie naar medicatieafspraak | MBH_MO_123_3_MA_1 | ||||
| MBH identificatie | MBH_MO_123_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||||
| Medicatie gebruik | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_MO_123_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Registratiedatum | T, om 12:58 | |||
| Gebruik indicator | Ja | |||
| Gebruiksperiode | Vanaf T- 10 dagen, tot en met T+ 1 dag, om 23:59 | |||
| Geneesmiddel - Product specificatie | ||||
| Product naam | Glimepiride | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T- 10 dagen, tot en met T+ 1 dag, om 23:59, 1 maal per dag 1 tablet | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| Auteur | Patiënt | |||
| Kopie indicator | Ja | |||
| MBH identificatie | MBH_MO_123_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
Medicamenteuze behandeling MBH_MO_123_4
| Medicatieafspraak | ||||||
| Gegevenselement | Waarde | |||||
| Identificatie | MBH_MO_123_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||||
| Afspraakdatum | T- 60 dagen, om 09:13 | |||||
| Gebruiksperiode | Vanaf T- 60 dagen, tot nader order | |||||
| Voorschrijver | ||||||
| Zorgverlener | ||||||
| Naamgegevens | I. Ternist | |||||
| Specialisme | Medisch specialisten, inwendige geneeskunde (code = '0313' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||||
| Zorgaanbieder | ||||||
| Zorgaanbieder identificatienummer | 00001113 (in identificerend systeem: URA) | |||||
| Organisatie naam | Antonius | |||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||||
| Geneesmiddel - primaire code | INSULINE GLARGINE INJVLST 100E/ML (code = '121312' in codeSystem 'G-Standaard PRK') | |||||
| Geneesmiddel - generiekere code | INSULINE GLARGINE INJVLST 100E/ML (code = '128651' in codeSystem 'G-Standaard GPK') | |||||
| Gebruiksinstructie | ||||||
| Omschrijving | Vanaf T- 60 dagen, tot nader order, 1 maal per dag 10IE, SUBCUTAAN | |||||
| Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||||
| Doseerinstructie | 1 maal per dag 10 internationale eenheid | |||||
| Kopie indicator | Ja | |||||
| MBH identificatie | MBH_MO_123_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||||
| Toedieningsafspraak | |||||
| Gegevenselement | Waarde | ||||
| Identificatie | MBH_MO_123_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
| Afspraakdatum | T- 60 dagen, om 15:55 | ||||
| Gebruiksperiode | Vanaf T- 60 dagen, tot nader order | ||||
| Verstrekker | |||||
| Zorgaanbieder | |||||
| Zorgaanbieder identificatie nummer | 13336578 (in identificerend systeem: URA) | ||||
| Organisatie naam | Poliapotheek Antonius | ||||
| Geneesmiddel - primaire code | LANTUS SOLOSTAR INJ 100E/ML PEN 3ML (code = '1859226' in codeSystem 'G-Standaard HPK') | ||||
| Geneesmiddel - generiekere code | INSULINE GLARGINE INJVLST 100E/ML (code = '121312' in codeSystem 'G-Standaard PRK') | ||||
| Geneesmiddel - generiekere code | INSULINE GLARGINE INJVLST 100E/ML (code = '128651' in codeSystem 'G-Standaard GPK') | ||||
| Gebruiksinstructie | |||||
| Omschrijving | Vanaf T- 60 dagen, tot nader order, Elke dag om 9 uur 10IE, subcutaan | ||||
| Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
| Doseerinstructie | elke dag om 10 internationale eenheid | ||||
| Kopie indicator | Ja | ||||
| Relatie naar medicatieafspraak | MBH_MO_123_4_MA_1 | ||||
| MBH identificatie | MBH_MO_123_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||||
Medicamenteuze behandeling MBH_MO_123_5
| Toedieningsafspraak | |||||
| Gegevenselement | Waarde | ||||
| Identificatie | MBH_MO_123_5_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
| Afspraakdatum | T- 36 dagen, om 15:55 | ||||
| Gebruiksperiode | Vanaf T- 36 dagen, gedurende 90 dagen | ||||
| Verstrekker | |||||
| Zorgaanbieder | |||||
| Zorgaanbieder identificatie nummer | 13336578 (in identificerend systeem: URA) | ||||
| Organisatie naam | Poliapotheek Antonius | ||||
| Geneesmiddel - primaire code | PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 8MG (code = '2105594' in codeSystem 'G-Standaard HPK') | ||||
| Geneesmiddel - generiekere code | PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '69523' in codeSystem 'G-Standaard PRK') | ||||
| Geneesmiddel - generiekere code | PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '117722' in codeSystem 'G-Standaard GPK') | ||||
| Gebruiksinstructie | |||||
| Omschrijving | Vanaf T- 36 dagen, gedurende 90 dagen, 1 maal per dag 1 tablet, oraal | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
| Doseerinstructie | 1 maal per dag 1 stuk | ||||
| Kopie indicator | Ja | ||||
| MBH identificatie | MBH_MO_123_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||||
| Medicatie gebruik | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_MO_123_5_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Registratiedatum | T- 33 dagen, om 13:58 | |||
| Gebruik indicator | Nee | |||
| Volgens afspraak indicator | Nee | |||
| Gebruiksperiode | Vanaf T- 34 dagen, tot nader order | |||
| Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | |||
| Geneesmiddel - primaire code | PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 8MG (code = '2105594' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '69523' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '117722' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T- 34 dagen, tot nader order, gestaakt | |||
| Gerelateerde afspraak : TA | MBH_MO_123_5_TA_1 | |||
| Auteur | Patiënt | |||
| Reden wijzigen of stoppen gebruik | Te sterk effect (code = '6' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | |||
| Kopie indicator | Ja | |||
| Toelichting | Gestopt vanwege bijwerkingen | |||
| MBH identificatie | MBH_MO_123_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
Medicamenteuze behandeling MBH_MO_123_6
| Medicatieafspraak | ||||||
| Gegevenselement | Waarde | |||||
| Identificatie | MBH_MO_123_6_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||||
| Afspraakdatum | T- 728 dagen, om 09:13 | |||||
| Gebruiksperiode | Vanaf T- 728 dagen, tot nader order | |||||
| Voorschrijver | ||||||
| Zorgverlener | ||||||
| Naamgegevens | John de Vries | |||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||||
| Zorgaanbieder | ||||||
| Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||||
| Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||||
| Geneesmiddel - primaire code | Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK') | |||||
| Geneesmiddel - generiekere code | Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK') | |||||
| Gebruiksinstructie | ||||||
| Omschrijving | Vanaf T- 728 dagen, tot nader order, 1 maal per dag 1 tablet 's avonds, oraal | |||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||||
| Doseerinstructie | 1 maal per dag 1 stuk 's avonds | |||||
| Kopie indicator | Ja | |||||
| MBH identificatie | MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||||
| Toedieningsafspraak | |||||
| Gegevenselement | Waarde | ||||
| Identificatie | MBH_MO_123_6_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
| Afspraakdatum | T- 323 dagen, om 15:55 | ||||
| Gebruiksperiode | Vanaf T- 323 dagen, tot nader order | ||||
| Verstrekker | |||||
| Zorgaanbieder | |||||
| Zorgaanbieder identificatie nummer | 13336578 (in identificerend systeem: URA) | ||||
| Organisatie naam | Poliapotheek Antonius | ||||
| Geneesmiddel - primaire code | SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK') | ||||
| Geneesmiddel - generiekere code | Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK') | ||||
| Geneesmiddel - generiekere code | Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK') | ||||
| Gebruiksinstructie | |||||
| Omschrijving | Vanaf T- 323 dagen, tot nader order, 1 maal per dag 2 tabletten 's avonds, oraal | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
| Doseerinstructie | 1 maal per dag 2 stuks 's avonds | ||||
| Kopie indicator | Ja | ||||
| Relatie naar medicatieafspraak | MBH_MO_123_6_MA_1 | ||||
| MBH identificatie | MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||||
| Medicatie gebruik | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_MO_123_6_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Registratiedatum | T- 248 dagen, om 09:00 | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Nee | |||
| Gebruiksperiode | Vanaf T- 248 dagen, tot nader order | |||
| Geneesmiddel - primaire code | SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T- 248 dagen, tot nader order, 1 maal per dag 1 tablet 's avonds, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk 's avonds | |||
| Auteur | Zorgverlener : I. Ternist - Medisch specialisten, inwendige geneeskunde. Antonius | |||
| Kopie indicator | Nee | |||
| Toelichting | Patiënt gebruikt niet volgens voorschrift | |||
| MBH identificatie | MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatie gebruik | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_MO_123_6_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| Registratiedatum | T- 172 dagen, om 15:37 | |||
| Gebruik indicator | Ja | |||
| Volgens afspraak indicator | Nee | |||
| Gebruiksperiode | Vanaf T- 248 dagen, tot en met T- 173 dagen, om 23:59 | |||
| Geneesmiddel - primaire code | SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Vanaf T- 248 dagen, tot en met T- 173 dagen, om 23:59, 1 maal per dag 1 tablet 's avonds, oraal, gestopt | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk 's avonds | |||
| Gerelateerde afspraak : MA | MBH_MO_123_6_MA_1 | |||
| Auteur | Patiënt | |||
| Toelichting | Veel last van jeuk | |||
| MBH identificatie | MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
Medicamenteuze behandeling MBH_MO_123_7
| Medicatieafspraak | ||||||
| Gegevenselement | Waarde | |||||
| Identificatie | MBH_MO_123_7_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||||
| Afspraakdatum | T+ 3 dagen, om 09:27 | |||||
| Gebruiksperiode | Vanaf T+ 3 dagen, tot en met T+ 17 dagen, om 23:59 | |||||
| Voorschrijver | ||||||
| Zorgverlener | ||||||
| Naamgegevens | John de Vries | |||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||||
| Zorgaanbieder | ||||||
| Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||||
| Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||||
| Geneesmiddel - primaire code | Flucloxacilline capsule 500mg (code = '5274' in codeSystem 'G-Standaard PRK') | |||||
| Geneesmiddel - generiekere code | Flucloxacilline capsule 500mg (code = '15466' in codeSystem 'G-Standaard GPK') | |||||
| Gebruiksinstructie | ||||||
| Omschrijving | Vanaf T+ 3 dagen, tot en met T+ 17 dagen, om 23:59, Elke 8 uur 1 capsule, oraal | |||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||||
| Doseerinstructie | 1 maal per dag 1 stuk | |||||
| Kopie indicator | Ja | |||||
| MBH identificatie | MBH_MO_123_7 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||||
Medicamenteuze behandeling MBH_MO_123_8
| Toedieningsafspraak | |||||
| Gegevenselement | Waarde | ||||
| Identificatie | MBH_MO_123_8_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
| Afspraakdatum | T- 28 dagen, om 11:50 | ||||
| Gebruiksperiode | Vanaf T- 45 dagen, tot en met T- 29 dagen, om 23:59 | ||||
| Stoptype | Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||
| Verstrekker | |||||
| Zorgaanbieder | |||||
| Zorgaanbieder identificatie nummer | 13336578 (in identificerend systeem: URA) | ||||
| Organisatie naam | Poliapotheek Antonius | ||||
| Reden afspraak | Beleidswijziging | ||||
| Geneesmiddel - primaire code | Atorvastatine ranbaxy tablet filmomhuld 40 mg (code = '2230879' in codeSystem 'G-Standaard HPK') | ||||
| Geneesmiddel - generiekere code | ATORVASTATINE TABLET 40MG (ALS CA-ZOUT-3-WATER) (code = '98620' in codeSystem 'G-Standaard PRK') | ||||
| Geneesmiddel - generiekere code | ATORVASTATINE TABLET 40MG (ALS CA-ZOUT-3-WATER) (code = '137219' in codeSystem 'G-Standaard GPK') | ||||
| Gebruiksinstructie | |||||
| Omschrijving | Vanaf T- 45 dagen, tot en met T- 29 dagen, om 23:59, 1 maal per dag 2 tabletten 's avonds, oraal | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
| Doseerinstructie | 1 maal per dag 2 stuks 's avonds | ||||
| Kopie indicator | Ja | ||||
| Relatie naar medicatieafspraak | MBH_MO_123_8_MA_3 | ||||
| MBH identificatie | MBH_MO_123_8 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||||
Medicamenteuze behandeling MBH_MO_123_9
| Medicatieafspraak | ||||||
| Gegevenselement | Waarde | |||||
| Identificatie | MBH_MO_123_9_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||||
| Afspraakdatum | T- 45 dagen, om 11:50 | |||||
| Gebruiksperiode | Vanaf T- 45 dagen, tot en met T- 31 dagen, om 23:59 | |||||
| Voorschrijver | ||||||
| Zorgverlener | ||||||
| Naamgegevens | John de Vries | |||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||||
| Zorgaanbieder | ||||||
| Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||||
| Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||||
| Geneesmiddel - primaire code | FLUCLOXACILLINE CAPSULE 500MG (code = '5274' in codeSystem 'G-Standaard PRK') | |||||
| Geneesmiddel - generiekere code | FLUCLOXACILLINE CAPSULE 500MG (code = '15466' in codeSystem 'G-Standaard GPK') | |||||
| Gebruiksinstructie | ||||||
| Omschrijving | Vanaf T- 45 dagen, tot en met T- 31 dagen, om 23:59, 1 keer per exact 8 uur 1 stuk, oraal | |||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||||
| Doseerinstructie | exact iedere 8 uur 1 stuk | |||||
| Kopie indicator | Ja | |||||
| MBH identificatie | MBH_MO_123_9 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||||
Medicamenteuze behandeling MBH_MO_123_10
| Toedieningsafspraak | |||||
| Gegevenselement | Waarde | ||||
| Identificatie | MBH_MO_123_10_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
| Afspraakdatum | T- 36 dagen, om 15:50 | ||||
| Gebruiksperiode | Vanaf T- 56 dagen, tot en met T- 37 dagen, om 23:59 | ||||
| Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||||
| Verstrekker | |||||
| Zorgaanbieder | |||||
| Zorgaanbieder identificatie nummer | 13336578 (in identificerend systeem: URA) | ||||
| Organisatie naam | Poliapotheek Antonius | ||||
| Reden afspraak | Geen of onvoldoende effect | ||||
| Geneesmiddel - primaire code | PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 4MG (code = '2105586' in codeSystem 'G-Standaard HPK') | ||||
| Geneesmiddel - generiekere code | PERINDOPRIL TABLET 4MG (ERBUMINE) (code = '29076' in codeSystem 'G-Standaard PRK') | ||||
| Geneesmiddel - generiekere code | PERINDOPRIL TABLET 4MG (ERBUMINE) (code = '75434' in codeSystem 'G-Standaard GPK') | ||||
| Gebruiksinstructie | |||||
| Omschrijving | Vanaf T- 56 dagen, tot en met T- 37 dagen, om 23:59, 1 maal per dag 1 tablet 's morgens, oraal | ||||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
| Doseerinstructie | 1 maal per dag 1 stuk 's ochtends | ||||
| Kopie indicator | Ja | ||||
| MBH identificatie | MBH_MO_123_10 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||||
Versiehistorie
| Versiegegevens | |
| Datum | Beschrijving |
| 26 aug 2019 | Issue MM-477 - adressoort toegevoegd bij alle adressen |